Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
After finishing at $0.62 in the prior trading day, Oncology Institute Inc (NASDAQ: TOI) closed at $0.72, up 14.56%. In other words, the price has increased by $14.56 from its previous closing price. On the day, 0.68 million shares were traded.
Ratios:
Our goal is to gain a better understanding of TOI by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.27 and its Current Ratio is at 2.49. In the meantime, Its Debt-to-Equity ratio is 7.94 whereas as Long-Term Debt/Eq ratio is at 7.51.
On September 14, 2022, Guggenheim started tracking the stock assigning a Buy rating and target price of $7.
On August 15, 2022, Jefferies started tracking the stock assigning a Buy rating and target price of $10.Jefferies initiated its Buy rating on August 15, 2022, with a $10 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 26 ’24 when Hively Brad bought 250,000 shares for $0.17 per share. The transaction valued at 42,500 led to the insider holds 616,753 shares of the business.
Hively Brad bought 50,000 shares of TOI for $7,500 on Dec 02 ’24. The Director now owns 666,753 shares after completing the transaction at $0.15 per share.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.14 while its Price-to-Book (P/B) ratio in mrq is 3.49.
Stock Price History:
Over the past 52 weeks, TOI has reached a high of $1.94, while it has fallen to a 52-week low of $0.13. The 50-Day Moving Average of the stock is 7.24%, while the 200-Day Moving Average is calculated to be 62.44%.
Shares Statistics:
A total of 75.56M shares are outstanding, with a floating share count of 36.80M. Insiders hold about 51.29% of the company’s shares, while institutions hold 15.03% stake in the company.
